H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on iTeos Therapeutics (NASDAQ: ITOS) to $54.00 (from $37.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE